Cowbell Announces Next Cycle of Growth, Profitability, and Global Expansion; Appoints John Botros as Chief Financial Officer
PLEASANTON, Calif., Jan. 5, 2026 /PRNewswire/ — Cowbell, a leading provider of adaptive cyber and specialty insurance solutions for global small and mid-market... Read more.
Jacobs to Acquire Remaining Stake in PA Consulting
Full ownership of a leading innovation and transformation consultancy enables Jacobs to realize value of future performance and accelerate our strategy to redefine... Read more.
Bybit Launches Program to Upskill Sri Lankan Creators with Fully Sponsored Market Education Program
DUBAI, UAE, Jan. 5, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has launched a fully sponsored... Read more.
DOOGEE “AI, Explore to More”: Empowering Real-World Adventure at CES 2026
LAS VEGAS, Jan. 5, 2026 /PRNewswire/ — This January, the future of exploration arrives. DOOGEE invites tech lovers, industry partners, and global media to... Read more.
Earendil Labs Announces Strategic Collaboration with Sanofi to Discover Bispecific Antibodies for Autoimmune Diseases
WILMINGTON, Del., Jan. 5, 2026 /PRNewswire/ — Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics,... Read more.
Prince Sultan Bin Mansour Al Saud Leads First Travel Group Delegation to TRANSSION, Forging New Opportunities in Emerging Markets
SHANGHAI, Jan. 5, 2026 /PRNewswire/ — TRANSSION’s Infinix brand hosted a high-level delegation led by H.R.H. Prince Sultan Bin Mansour Al Saud, Chairman... Read more.
BENTELER acquires Deutsche Bahn company ioki, creating first European full-service provider for autonomous mobility
Unique group of companies accelerating the mobility transition: Autonomous vehicles, operational services and software-based mobility solutions “made in Europe”... Read more.
Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
COPENHAGEN, Denmark, Jan. 5, 2026 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – (CPH: CURAS) a clinical-stage theranostic... Read more.
Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC
CHENGDU, China, Jan. 5, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech” or the “Company,”... Read more.
ez1099: A Trusted Solution for On-Time 1099 Filing with Add-On E-File
ez1099 empowers Human Resources to manage contractor reporting with confidence and ease REDMOND, Wash., Jan. 5, 2026 /PRNewswire/ — As businesses prepare for... Read more.